Inducing autoimmune disease to treat cancer
Open Access
- 11 May 1999
- journal article
- editorial
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 96 (10) , 5340-5342
- https://doi.org/10.1073/pnas.96.10.5340
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 MelanomaThe Journal of Experimental Medicine, 1997
- Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T LymphocytesThe Journal of Experimental Medicine, 1996
- Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.The Journal of Experimental Medicine, 1996
- Update: Releasing the Brakes on Antitumor Immune ResponseScience, 1996
- Enhancement of Antitumor Immunity by CTLA-4 BlockadeScience, 1996
- A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1994
- Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell LinesScience, 1994
- Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.The Journal of Experimental Medicine, 1994
- Self-Determinant Selection and Selective RegulationPublished by S. Karger AG ,1994
- Unique Tumor-Specific AntigensAnnual Review of Immunology, 1988